Tradestie Institutional Equity Comparison Engine
MBRX vs CAPR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CAPR Overall Edge
CAPR Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Valuation, Options & Structure while MBRX counters with relative strength in Momentum & Technical. Fundamentally, MBRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, MBRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CAPR
MBRX N/M vs CAPR 78.7x Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs -7.9%
Momentum & Technical Winner
MBRX
1Y +1547.9% vs +44.3% ยท 52W Pos 73% vs 15%
Options & Structure Winner
CAPR
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (89th %ile IV)
MBRX
NASDAQ
Moleculin Biotech, Inc.
Pharmaceutical Preparations
$7.48
-4.96% 1D
Market Cap
$7.9M
1M Return
+2567.62%
1Y Return
+1547.94%
Forward P/E
N/M
Unified AI Score
35.5 / 100
SELL
Tech 24.0
Fund 33.0
Flow 50.0
Mom 40.0
CAPR
NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap
$595.4M
1M Return
+26.23%
1Y Return
+44.29%
Forward P/E
78.7x
Unified AI Score
28.0 / 100
SELL
Tech 50.0
Fund 37.0
Flow 68.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MBRX +1547.94%
CAPR +44.29%
Spread: +1501.15 pp (MBRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MBRX TTM Op. Margin: 0.0%
CAPR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBRX vs CAPR. Trailing 12-month operating profitability (MBRX 0.0% vs CAPR 0.0%) and valuation multiples (MBRX N/M vs CAPR 78.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MBRX | CAPR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.9M | $595.4M | Larger Scale | CAPR |
| Trailing P/E Ratio Valuation | 0.0x | 78.7x | Lower Multiple | MBRX |
| Forward P/E Ratio Valuation | N/M | 78.7x | Lower Multiple | CAPR |
| Revenue Growth (YoY) Growth | +0.0% | -7.9% | Higher Growth | MBRX |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1371.6% | -100.5% | Higher ROE | CAPR |
| 52-Week Range Position Momentum | 73% ($0โ$10) | 15% ($3โ$40) | Stronger Trend | MBRX |
| Beta / 30D Volatility Risk Regime | 4.61ฮฒ ยท 7732% Vol | 1.52ฮฒ ยท 152% Vol | Lower Realized Risk | CAPR |
| Unified Institutional Score Composite Signal | 35.5 / 100 (SELL) | 28.0 / 100 (SELL) | Higher Composite | MBRX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MBRX vs CAPR Buy Guide
MBRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CAPR
CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
89th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MBRX nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.